20 March 2020
Visiongain has launched a new pharma report: Pharma Clinical Trial Services Market and Industry Forecast 2020-2030: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Disease.
This report encompasses the global market for pharmaceutical clinical trial services. It provides a comprehensive and critical analysis of the market, including the subsectors of early phase services and late phase services. The report also assesses the key therapeutic areas in which leading clinical research organizations (CROs) operate, namely, cancer, cardiovascular disease, CNS disease, infectious diseases and metabolic disease.
The lead analyst of the report commented "Biotech, pharmaceutical & medical device companies continue to develop at a fast pace owing to continuous expenditure on R&D, rising demand for biopharmaceuticals and increased healthcare needs for the geriatric population. In order to fulfil this, the demand for effective clinical trials has increased in order to ensure the effectiveness and safety of products. This demand is further propelled by the increasing importance of contract research organizations in emerging markets. The main challenges faced in this market are the lengthy authorisation, and approval procedures imposed by regulatory authorities."
Leading companies featured in the report include Quintiles, Laboratory Corporation of America (LabCorp), Pharmaceutical Product Development (PPD), Parexel International, ICON, INC Research Holdings, inVentiv Health & Other Companies
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
12 January 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
11 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.